Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating the combination of gemcitabine and cisplatin for patients with recurrent or platinum-refractory ovarian ca…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [Phase 3]
This clinical trial update reports the completion of a Phase 3 study evaluating paclitaxel plus cisplatin in patients with stage III or IV o…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer [Phase 1]
This update summarizes a Phase 1 clinical trial evaluating paclitaxel in patients with recurrent or persistent ovarian cancer or primary per…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 trial evaluating the combination of topotecan and etoposide in patients with recurrent ovarian, fallopian tube, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer [Phase 1]
A Phase 1 study of a combination chemotherapy regimen for stage III/IV ovarian epithelial cancer or primary peritoneal cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Quality of Life in Survivors of Gynecologic Cancer
This completed clinical trial update reports on quality of life outcomes among survivors of gynecologic cancers, specifically endometrial an…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
This is a Phase 1 study of a combination chemotherapy regimen in patients with untreated ovarian cancer, fallopian tube cancer, or primary p…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating a combination chemotherapy regimen for stage III epithelial ovarian cancer and primary peritoneal cancer has comp…
-
CLINICAL_TRIALS trial_result · 2013-05-21Clinical Trial Update: Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients [Phase 2]
Phase 2 trial evaluating bevacizumab with gemcitabine, docetaxel, melphalan, and carboplatin in ovarian cancer; the study was terminated and…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: Abraxane/Bevacizumab [Phase 2]
A Phase 2 trial of Abraxane (nab-paclitaxel) in combination with Bevacizumab for ovarian cancer and peritoneal cancer was terminated, with r…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating cisplatin in combination with flavopiridol for advanced or recurrent ovarian epithelial cancer and recurrent primar…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing [Phase 1]
A Phase 1 study of ZYC300 with cyclophosphamide pre-dosing has completed, evaluating its use in breast cancer and ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood [Phase 2]
Phase 2 trial evaluating carboplatin/paclitaxel with pegfilgrastim supported by hematopoietic progenitor cell re-infusion in whole blood in …
-
CLINICAL_TRIALS research · 2013-05-13Clinical Trial Update: Validation of a Nutrition Screening Tool
Clinical trial update reporting the completion of a study validating a nutrition screening tool across multiple cancer types.
-
CLINICAL_TRIALS research · 2013-05-10Clinical Trial Update: A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer
Clinical trial update comparing docetaxel plus lobaplatin versus docetaxel plus carboplatin in platinum-sensitive relapsed ovarian cancer, w…
-
CLINICAL_TRIALS trial_result · 2013-05-07Clinical Trial Update: Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection [Phase 2]
Phase 2 trial investigating canine scent detection to distinguish lung cancer from gynecological cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect [Phase 1, Phase 2]
Phase I/II clinical trial updating escalating-dose melphalan with autologous stem cell support and amifostine cytoprotection across multiple…
-
CLINICAL_TRIALS research · 2013-04-24Clinical Trial Update: Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy [Phase 2]
A Phase 2 clinical study evaluating intraperitoneal bevacizumab combined with intraperitoneal hyperthermic perfusion chemotherapy for malign…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer
This clinical trial update presents results from a study examining prostaglandin metabolites in urine samples from patients with ovarian can…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating the combination chemotherapy plus peripheral stem cell transplantation in patients with Stage III/IV ovarian canc…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [Phase 2]
This update describes a Phase 2 trial of a vaccine therapy for stage III or IV ovarian epithelial cancer. The study has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of docetaxel in patients with recurrent or refractory ovarian cancer or primary peritoneal cancer; the study status is termina…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer [Phase 2]
A Phase 2 trial evaluating capecitabine for recurrent ovarian epithelial cancer or primary peritoneal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [Phase 2]
Phase 2 trial of amifostine for gynecologic cancers has been terminated (including ovarian, primary peritoneal, fallopian tube, cervical, ut…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel for ovarian cancer and primary peritoneal cancer has been terminated.